We use cookies for a better user experience. Read our Privacy Policy

I Agree

Multiplex Assays Market Analysis, 2018 - 2026

Multiplex Assays Market (Product- Instruments, Consumables (Reagents and Kits, Micropipettes and Microplates), Software; Technology - Multiplex RT-PCR, Flow Cytometry, Fluorescence, Luminescence; Type - Protein (Planar, Bead based), Nucleic Acid (Planar, Bead based), Cell; Application - Research and Development (Drug Discovery and Development, Biomarker Research and Application), Diagnosis (Infectious Diseases, Autoimmune Diseases, Cancer, Cardiovascular Diseases, Neuro-endocrine Diseases); End use - Academic and Research Centers, Diagnostic Centers, Biotechnology and Biopharmaceutical Companies, Hospitals) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Global Multiplex Assays Market - Snapshot

Multiplex assays can be defined as the type of immunoassay that employs magnetic beads for simultaneously measuring a range of analytes in a single reaction. Multiplex assays are considered to be derivatives of enzyme linked immunosorbent assay (ELISA). However, these are preferred over singleplex ELISA, owing to their advantages such as high throughput, greater output per sample volume, and increased efficiency.

The global multiplex assays market is anticipated to reach US$ 4,277.31 Mn by 2026, expanding at a CAGR of 7.90% from 2018 to 2026. Expansion of the market can be attributed to the advantages offered by multiplex assays over singleplex assays, rising prevalence of infectious diseases and cancer that can be detected easily at earlier stages, government and private funding for carrying out research, and strategic acquisitions among market players to enhance the reach of the multiplex assay kits. However, the high cost of instruments used to perform multiplex assays, non-availability of diagnostic kits, and lack of skilled labor are anticipated to restrain the market.

In terms of product, the market has been segmented into instruments, consumables, and software. The consumables segment has been further sub-segmented into reagents and kits, microplates and micropipettes, and others. Consumables was the dominant segment in 2017. It is anticipated to remain dominant during the forecast period. It is anticipated to propel at a high CAGR during the forecast period, owing to the significant increase in focus on research and development by major market players, which would lead to repeat orders for consumables, contributing to the rise in revenues. Among the consumables segment, the reagents and kits sub-segment is expected to account for a major share of the consumables segment, in terms of revenue, during the forecast period.

multiplex-assays-market.jpg

Based on technology, the market has been classified into multiplex RT-PCR, flow cytometry, fluorescence, luminescence, and others. The flow cytometry segment dominated the market in 2017. It is anticipated to remain dominant during the forecast period. Robust expansion of the segment can be attributed to the ease of performing multiplex assays through this technology, which offers the flexibility of running a large number of samples simultaneously with accuracy. This, in turn, fuels the segment. Additionally, the focus on development of multiplex bead-based assays for flow cytometers propels the segment.

In terms of type, the market has been segregated into protein, nucleic acid, and cell. The protein segment has been further sub-segmented into planar and bead-based. The nucleic acid segment has been split into planar and bead-based. The protein segment dominated the market in 2017. It is expected to expand at a significant CAGR during the forecast period. Expansion of the segment can be attributed to the increase in analyzing protein samples precisely and simultaneously for dynamic and static as well as predictive, descriptive, and biological research. In terms of protein segment, the bead-based sub-segment is anticipated to remain dominant during the forecast period, owing to its application in the analysis of various infectious diseases and autoimmune diseases.

Based on application, the market has been divided into research & development, diagnosis, and others. The research & development segment has been further segmented into drug discovery & development and biomarker research & application. The diagnosis segment has been further sub-split into infectious diseases, autoimmune diseases, cancer, cardiovascular diseases, neuro-endocrine diseases, and others. The research & development segment is expected to expand at a notable CAGR during the forecast period, due to rise in focus of market players on investments in their research on multiplex assays. Moreover, increasing availability of multiplex kits approved only for research purposes and government and non-government funding for research aid in the growth of the segment.

In terms of end-user, the market has been bifurcated into academic and research centers, biotechnology and biopharmaceutical companies, diagnostic centers, hospitals, and others. The biotechnology and biopharmaceutical companies segment dominated the market in 2017. It is expected to remain lucrative during the forecast period. Expansion of the segment can be attributed to the increase in focus on the establishment of biotechnology companies in emerging economies. Furthermore, increase in the number of biotechnology companies, globally, particularly in Europe and Asia, is expected to boost the segment.

In terms of region, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe, cumulatively, accounted for over 68% of the market. They and are anticipated to remain dominant in terms of revenue during the forecast period. North America is anticipated to remain dominant during the forecast period owing to the presence of leading market players in the region, aiding in the easy and rapid availability of instruments and reagents for conducting assays and the strategic mergers and partnerships among players. The market in Asia Pacific is anticipated to expand at a significant pace during the forecast period. Expansion of the market in the region is expected to be contributed by India and Japan, due to the rise in the geriatric population leading to the increase in prevalence of infectious diseases owing to the weakening immune system.

Key companies operating in the global multiplex assays market include Luminex Corporation, Thermo Fisher Scientific, Inc., Seegene, Inc., Meso Scale Diagnostics, LLC., Abcam plc, Bio-Rad Laboratories, Inc., QIAGEN N.V., Merck KGaA, Quansys Biosciences, and Illumina, Inc.

The global multiplex assays market has been segmented as follows:

by Product

  • Instruments
  • Consumables
    • Reagents & Kits
    • Micropipettes & Microplates
    • Others
  • Software

by Technology

  • Multiplex RT-PCR
  • Flow Cytometry
  • Luminescence
  • Fluorescence
  • Others

by Type

  • Protein
    • Planar
    • Bead-based
  • Nucleic Acid
    • Planar
    • Bead-based
  • Cell

by Application

  • Research & Development
    • Drug Discovery & Research
    • Biomarker Research & Application
  • Diagnosis
    • Infectious Diseases
    • Autoimmune Diseases
    • Cancer
    • Cardiovascular Diseases
    • Neuro-endocrine Diseases
    • Others
  • Others

by End-user

  • Biotechnology & Biopharmaceutical Companies
  • Academic & Research Centers
  • Diagnostic Centers
  • Hospitals
  • Others

by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of multiplex assays market?

Multiplex assays market is anticipated to reach US$ 4,277.31 Mn by 2026

What is the anticipated CAGR of the multiplex assays market in the forecast period?

Multiplex assays market is projected to rise at healthy 7.90% CAGR between 2018 and 2026

What are the key driving factors for the growth of the multiplex assays market?

Multiplex assays market is driven by rising use of companion diagnostics to increase the efficacy of therapies

Which is the rising prominent segment in the multiplex assays market?

Consumables was the dominant segment, and it is anticipated to remain dominant during the forecast period

Who are the key players in the global multiplex assays market?

Key players in the global multiplex assays market are Seegene, Inc., Thermo Fisher Scientific, Inc., Abcam plc, Meso Scale Diagnostics, LLC., and Bio-Rad Laboratories, Inc.

1. Preface
     1.1. Report Scope and Market Segmentation
     1.2. Research Highlights

2. Assumptions and Acronyms Used

3. Research Methodology

4. Executive Summary

5. Market Overview
     5.1. Product Overview
     5.2. Market Dynamics
            5.2.1. Drivers
                     5.2.1.1. Advantages of multiplex assays over singleplex assays
                     5.2.1.2. Government and non-government funding
                     5.2.1.3. Rise in prevalence of infectious diseases and cancer
                     5.2.1.4. Strategic acquisitions and partnerships
                     5.2.1.5. Increasing applications of multiplex assays
                     5.2.1.6. Significant product launches
            5.2.2. Restraints
                     5.2.2.1. Lack of skilled labor
                     5.2.2.2. High cost of multiplex assay systems
                     5.2.2.3. Constraints of multiplex assays
                     5.2.2.4. Stringent regulatory environment
                     5.2.2.5. Product recalls
            5.2.3. Opportunities
                     5.2.3.1. Rise in focus on multiplexed point-of-care testing
                     5.2.3.2. Combining multiplex assays with microchip arrays
            5.2.4. Trends
                     5.2.4.1. Increase in the number of biotechnology companies
                     5.2.4.2. Growing need for personalized medicine
     5.3. Global Multiplex Assays Market Value (US$ Mn) Forecast, 2016?2026
     5.4. Global Multiplex Assays Market Outlook
     5.5. Key Industry Developments
     5.6. Porter's Five Forces Analysis
     5.7. Comparative Analysis - Multiplex Assays vs Singleplex Assays
     5.8. Comparative Analysis - Planar and Bead-based Multiplex Assays
     5.9. Multiplex Assay – Steps Involved
     5.10. Value Chain Analysis
     5.11. Multiplex Assays – List of Distributors
     5.12. Key Regulatory Agencies
     5.13. Regulatory Approval Process
            5.13.1. U.S.
            5.13.2. Europe
            5.13.3. Asia Pacific
            5.13.4. Latin America
            5.13.5. Middle East & Africa

6. Global Multiplex Assays Market Analysis, by Product
     6.1. Introduction
     6.2. Key Findings
     6.3. Global Multiplex Assays Market Value Share Analysis, by Product
     6.4. Global Multiplex Assays Market Value Forecast, by Product, 2016?2026
            6.4.1. Instruments
            6.4.2. Consumables
                     6.4.2.1. Reagents & Kits
                     6.4.2.2. Micropipettes & Microplates
                     6.4.2.3. Others
            6.4.3. Software
     6.5. Global Multiplex Assays Market Attractiveness, by Product

7. Global Multiplex Assays Market Analysis, by Technology
     7.1. Introduction
     7.2. Key Findings
     7.3. Global Multiplex Assays Market Value Share Analysis, by Technology
     7.4. Global Multiplex Assays Market Value Forecast, by Technology, 2016?2026
            7.4.1. Multiplex RT-PCR
            7.4.2. Flow Cytometry
            7.4.3. Luminescence
            7.4.4. Fluorescence
            7.4.5. Others
     7.5. Global Multiplex Assays Market Attractiveness, by Technology

8. Global Multiplex Assays Market Analysis, by Type
     8.1. Introduction
     8.2. Key Findings
     8.3. Global Multiplex Assays Market Value Share Analysis, by Type
     8.4. Global Multiplex Assays Market Value Forecast, by Type, 2016?2026
            8.4.1. Protein
                     8.4.1.1. Planar
                     8.4.1.2. Bead-based
            8.4.2. Nucleic Acid
                     8.4.2.1. Planar
                     8.4.2.2. Bead-based
            8.4.3. Cell
     8.5. Global Multiplex Assays Market Attractiveness, by Type

9. Global Multiplex Assays Market Analysis, by Application
     9.1. Introduction
     9.2. Key Findings
     9.3. Global Multiplex Assays Market Value Share Analysis, by Application
     9.4. Global Multiplex Assays Market Value Forecast, by Application, 2016?2026
            9.4.1. Research & Development
                     9.4.1.1. Drug Discovery & Research
                     9.4.1.2. Biomarker Research & Application
            9.4.2. Diagnosis
                     9.4.2.1. Infectious Diseases
                     9.4.2.2. Autoimmune Diseases
                     9.4.2.3. Cancer
                     9.4.2.4. Cardiovascular Diseases
                     9.4.2.5. Neuro-endocrine Diseases
                     9.4.2.6. Others
            9.4.3. Others
     9.5. Global Multiplex Assays Market Attractiveness, by Application

10. Global Multiplex Assays Market Analysis, by End-user
     10.1. Introduction
     10.2. Key Findings
     10.3. Global Multiplex Assays Market Value Share Analysis, by End-user
     10.4. Global Multiplex Assays Market Value Forecast, by End-user, 2016?2026
            10.4.1. Academic & Research Centers
            10.4.2. Biotechnology & Biopharmaceutical Companies
            10.4.3. Diagnostic Centers
            10.4.4. Hospitals
            10.4.5. Others
     10.5. Global Multiplex Assays Market Attractiveness, by End-user

11. Global Multiplex Assays Market Analysis and Forecasts, by Region
     11.1. Introduction
     11.2. Regional Outlook
     11.3. Global Multiplex Assays Market Value Forecast, by Region, 2016–2026
            11.3.1. North America
            11.3.2. Europe
            11.3.3. Asia-Pacific
            11.3.4. Latin America
            11.3.5. Middle East & Africa
     11.4. Global Multiplex Assays Market Attractiveness Analysis, by Region

12. North America Multiplex Assays Market Analysis
     12.1. Key Findings
     12.2. North America Multiplex Assays Market Value Forecast by Country, 2016?2026
            12.2.1. U.S.
            12.2.2. Canada
     12.3. North America Multiplex Assays Market Value Forecast, by Product, 2016?2026
            12.3.1. Instruments
            12.3.2. Consumables
                     12.3.2.1. Reagents & Kits
                     12.3.2.2. Micropipettes & Microplates
                     12.3.2.3. Others
            12.3.3. Software
     12.4. North America Multiplex Assays Market Value Forecast, by Technology, 2016?2026
            12.4.1. Multiplex RT-PCR
            12.4.2. Flow Cytometry
            12.4.3. Luminescence
            12.4.4. Fluorescence
            12.4.5. Others
     12.5. North America Multiplex Assays Market Value Forecast, by Type, 2016?2026
            12.5.1. Protein
                     12.5.1.1. Planar
                     12.5.1.2. Bead-based
            12.5.2. Nucleic Acid
                     12.5.2.1. Planar
                     12.5.2.2. Bead-based
            12.5.3. Cell
     12.6. North America Multiplex Assays Market Value Forecast, by Application, 2016?2026
            12.6.1. Research & Development
                     12.6.1.1. Drug Discovery & Research
                     12.6.1.2. Biomarker Research & Application
            12.6.2. Diagnosis
                     12.6.2.1. Infectious Diseases
                     12.6.2.2. Autoimmune Diseases
                     12.6.2.3. Cancer
                     12.6.2.4. Cardiovascular Diseases
                     12.6.2.5. Neuro-endocrine Diseases
                     12.6.2.6. Others
            12.6.3. Others
     12.7. North America Multiplex Assays Market Value Forecast, by End-user, 2016?2026
            12.7.1. Academic & Research Centers
            12.7.2. Biotechnology & Biopharmaceutical Companies
            12.7.3. Diagnostic Centers
            12.7.4. Hospitals
            12.7.5. Others
     12.8. North America Multiplex Assays Market Attractiveness
            12.8.1. By Country
            12.8.2. By Product
            12.8.3. By Technology
            12.8.4. By Type
            12.8.5. By Application
            12.8.6. By End-user

13. Europe Multiplex Assays Market Analysis
     13.1. Key Findings
     13.2. Europe Multiplex Assays Market Value Forecast by Country, 2016?2026
            13.2.1. Germany
            13.2.2. U.K.
            13.2.3. France
            13.2.4. Italy
            13.2.5. Spain
            13.2.6. Rest of Europe
     13.3. Europe Multiplex Assays Market Value Forecast, by Product, 2016?2026
            13.3.1. Instruments
            13.3.2. Consumables
                     13.3.2.1. Reagents & Kits
                     13.3.2.2. Micropipettes & Microplates
                     13.3.2.3. Others
            13.3.3. Software
     13.4. Europe Multiplex Assays Market Value Forecast, by Technology, 2016?2026
            13.4.1. Multiplex RT-PCR
            13.4.2. Flow Cytometry
            13.4.3. Luminescence
            13.4.4. Fluorescence
            13.4.5. Others
     13.5. Europe Multiplex Assays Market Value Forecast, by Type, 2016?2026
            13.5.1. Protein
                     13.5.1.1. Planar
                     13.5.1.2. Bead-based
            13.5.2. Nucleic Acid
                     13.5.2.1. Planar
                     13.5.2.2. Bead-based
            13.5.3. Cell
     13.6. Europe Multiplex Assays Market Value Forecast, by Application, 2016?2026
            13.6.1. Research & Development
                     13.6.1.1. Drug Discovery & Research
                     13.6.1.2. Biomarker Research & Application
            13.6.2. Diagnosis
                     13.6.2.1. Infectious Diseases
                     13.6.2.2. Autoimmune Diseases
                     13.6.2.3. Cancer
                     13.6.2.4. Cardiovascular Diseases
                     13.6.2.5. Neuro-endocrine Diseases
                     13.6.2.6. Others
            13.6.3. Others
     13.7. Europe Multiplex Assays Market Value Forecast, by End-user, 2016?2026
            13.7.1. Academic & Research Centers
            13.7.2. Biotechnology & Biopharmaceutical Companies
            13.7.3. Diagnostic Centers
            13.7.4. Hospitals
            13.7.5. Others
     13.8. Europe Multiplex Assays Market Attractiveness
            13.8.1. By Country
            13.8.2. By Product
            13.8.3. By Technology
            13.8.4. By Type
            13.8.5. By Application
            13.8.6. By End-user

14. Asia Pacific Multiplex Assays Market Analysis
     14.1. Key Findings
     14.2. Asia Pacific Multiplex Assays Market Value Forecast by Country, 2016?2026
            14.2.1. China
            14.2.2. India
            14.2.3. Japan
            14.2.4. Australia
            14.2.5. Rest of Asia Pacific
     14.3. Asia Pacific Multiplex Assays Market Value Forecast, by Product, 2016?2026
            14.3.1. Instruments
            14.3.2. Consumables
                     14.3.2.1. Reagents & Kits
                     14.3.2.2. Micropipettes & Microplates
                     14.3.2.3. Others
            14.3.3. Software
     14.4. Asia Pacific Multiplex Assays Market Value Forecast, by Technology, 2016?2026
            14.4.1. Multiplex RT-PCR
            14.4.2. Flow Cytometry
            14.4.3. Luminescence
            14.4.4. Fluorescence
            14.4.5. Others
     14.5. Asia Pacific Multiplex Assays Market Value Forecast, by Type, 2016?2026
            14.5.1. Protein
                     14.5.1.1. Planar
                     14.5.1.2. Bead-based
            14.5.2. Nucleic Acid
                     14.5.2.1. Planar
                     14.5.2.2. Bead-based
            14.5.3. Cell
     14.6. Asia Pacific Multiplex Assays Market Value Forecast, by Application, 2016?2026
            14.6.1. Research & Development
                     14.6.1.1. Drug Discovery & Research
                     14.6.1.2. Biomarker Research & Application
            14.6.2. Diagnosis
                     14.6.2.1. Infectious Diseases
                     14.6.2.2. Autoimmune Diseases
                     14.6.2.3. Cancer
                     14.6.2.4. Cardiovascular Diseases
                     14.6.2.5. Neuro-endocrine Diseases
                     14.6.2.6. Others
            14.6.3. Others
     14.7. Asia Pacific Multiplex Assays Market Value Forecast, by End-user, 2016?2026
            14.7.1. Academic & Research Centers
            14.7.2. Biotechnology & Biopharmaceutical Companies
            14.7.3. Diagnostic Centers
            14.7.4. Hospitals
            14.7.5. Others
     14.8. Asia Pacific Multiplex Assays Market Attractiveness
            14.8.1. By Country
            14.8.2. By Product
            14.8.3. By Technology
            14.8.4. By Type
            14.8.5. By Application
            14.8.6. By End-user

15. Latin America Multiplex Assays Market Analysis
     15.1. Key Findings
     15.2. Latin America Multiplex Assays Market Value Forecast by Country, 2016?2026
            15.2.1. Brazil
            15.2.2. Mexico
            15.2.3. Rest of Latin America
     15.3. Latin America Multiplex Assays Market Value Forecast, by Product, 2016?2026
            15.3.1. Instruments
            15.3.2. Consumables
                     15.3.2.1. Reagents & Kits
                     15.3.2.2. Micropipettes & Microplates
                     15.3.2.3. Others
            15.3.3. Software
     15.4. Latin America Multiplex Assays Market Value Forecast, by Technology, 2016?2026
            15.4.1. Multiplex RT-PCR
            15.4.2. Flow Cytometry
            15.4.3. Luminescence
            15.4.4. Fluorescence
            15.4.5. Others
     15.5. Latin America Multiplex Assays Market Value Forecast, by Type, 2016?2026
            15.5.1. Protein
                     15.5.1.1. Planar
                     15.5.1.2. Bead-based
            15.5.2. Nucleic Acid
                     15.5.2.1. Planar
                     15.5.2.2. Bead-based
            15.5.3. Cell
     15.6. Latin America Multiplex Assays Market Value Forecast, by Application, 2016?2026
            15.6.1. Research & Development
                     15.6.1.1. Drug Discovery & Research
                     15.6.1.2. Biomarker Research & Application
            15.6.2. Diagnosis
                     15.6.2.1. Infectious Diseases
                     15.6.2.2. Autoimmune Diseases
                     15.6.2.3. Cancer
                     15.6.2.4. Cardiovascular Diseases
                     15.6.2.5. Neuro-endocrine Diseases
                     15.6.2.6. Others
            15.6.3. Others
     15.7. Latin America Multiplex Assays Market Value Forecast, by End-user, 2016?2026
            15.7.1. Academic & Research Centers
            15.7.2. Biotechnology & Biopharmaceutical Companies
            15.7.3. Diagnostic Centers
            15.7.4. Hospitals
            15.7.5. Others
     15.8. Latin America Multiplex Assays Market Attractiveness
            15.8.1. By Country
            15.8.2. By Product
            15.8.3. By Technology
            15.8.4. By Type
            15.8.5. By Application
            15.8.6. By End-user

16. Middle East & Africa Multiplex Assays Market Analysis
     16.1. Key Findings
     16.2. Middle East & Africa Multiplex Assays Market Value Forecast by Country, 2016?2026
            16.2.1. GCC Countries
            16.2.2. Israel
            16.2.3. South Africa
            16.2.4. Rest of Middle East & Africa
     16.3. Middle East & Africa Multiplex Assays Market Value Forecast, by Product, 2016?2026
            16.3.1. Instruments
            16.3.2. Consumables
                     16.3.2.1. Reagents & Kits
                     16.3.2.2. Micropipettes & Microplates
                     16.3.2.3. Others
            16.3.3. Software
     16.4. Middle East & Africa Multiplex Assays Market Value Forecast, by Technology, 2016?2026
            16.4.1. Multiplex RT-PCR
            16.4.2. Flow Cytometry
            16.4.3. Luminescence
            16.4.4. Fluorescence
            16.4.5. Others
     16.5. Middle East & Africa Multiplex Assays Market Value Forecast, by Type, 2016?2026
            16.5.1. Protein
                     16.5.1.1. Planar
                     16.5.1.2. Bead-based
            16.5.2. Nucleic Acid
                     16.5.2.1. Planar
                     16.5.2.2. Bead-based
            16.5.3. Cell
     16.6. Middle East & Africa Multiplex Assays Market Value Forecast, by Application, 2016?2026
            16.6.1. Research & Development
                     16.6.1.1. Drug Discovery & Research
                     16.6.1.2. Biomarker Research & Application
            16.6.2. Diagnosis
                     16.6.2.1. Infectious Diseases
                     16.6.2.2. Autoimmune Diseases
                     16.6.2.3. Cancer
                     16.6.2.4. Cardiovascular Diseases
                     16.6.2.5. Neuro-endocrine Diseases
                     16.6.2.6. Others
            16.6.3. Others
     16.7. Middle East & Africa Multiplex Assays Market Value Forecast, by End-user, 2016?2026
            16.7.1. Academic & Research Centers
            16.7.2. Biotechnology & Biopharmaceutical Companies
            16.7.3. Diagnostic Centers
            16.7.4. Hospitals
            16.7.5. Others
     16.8. Middle East & Africa Multiplex Assays Market Attractiveness
            16.8.1. By Country
            16.8.2. By Product
            16.8.3. By Technology
            16.8.4. By Type
            16.8.5. By Application
            16.8.6. By End-user

17. Competitive Landscape
     17.1. Competition Matrix
     17.2. Company Profiles
            17.2.1. Luminex Corporation
                     17.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.1.2. Financial Overview
                     17.2.1.3. Product Portfolio
                     17.2.1.4. SWOT Analysis
                     17.2.1.5. Strategic Overview
            17.2.2. Thermo Fisher Scientific, Inc.
                     17.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.2.2. Financial Overview
                     17.2.2.3. Product Portfolio
                     17.2.2.4. SWOT Analysis
                     17.2.2.5. Strategic Overview
            17.2.3. Seegene, Inc.
                     17.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.3.2. Financial Overview
                     17.2.3.3. Product Portfolio
                     17.2.3.4. SWOT Analysis
                     17.2.3.5. Strategic Overview
            17.2.4. Meso Scale Diagnostics, LLC.
                     17.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.4.2. Product Portfolio
                     17.2.4.3. SWOT Analysis
                     17.2.4.4. Strategic Overview
            17.2.5. Abcam plc
                     17.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.5.2. Financial Overview
                     17.2.5.3. Product Portfolio
                     17.2.5.4. SWOT Analysis
                     17.2.5.5. Strategic Overview
            17.2.6. Bio-Rad Laboratories, Inc.
                     17.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.6.2. Financial Overview
                     17.2.6.3. Product Portfolio
                     17.2.6.4. SWOT Analysis
                     17.2.6.5. Strategic Overview
            17.2.7. QIAGEN N.V.
                     17.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.7.2. Financial Overview
                     17.2.7.3. Product Portfolio
                     17.2.7.4. SWOT Analysis
                     17.2.7.5. Strategic Overview
            17.2.8. Merck KGaA
                     17.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.8.2. Financial Overview
                     17.2.8.3. Product Portfolio
                     17.2.8.4. SWOT Analysis
                     17.2.8.5. Strategic Overview
            17.2.9. Quansys Biosciences
                     17.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.9.2. Product Portfolio
                     17.2.9.3. SWOT Analysis
            17.2.10. Illumina, Inc.
                     17.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                     17.2.10.2. Financial Overview
                     17.2.10.3. Product Portfolio
                     17.2.10.4. SWOT Analysis
                     17.2.10.5. Strategic Overview

List of Tables

Table 01: Multiplex Assays– List of Distributors 
Table 02: Key Regulatory Agencies
Table 03: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 04: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Consumables, 2016–2026
Table 05: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016–2026
Table 06: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 07: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016–2026
Table 08: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016–2026
Table 09: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 10: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016–2026
Table 11: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016–2026
Table 12: Global Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 13: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 14: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 15: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 16: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Consumables, 2016–2026
Table 17: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016–2026
Table 18: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 19: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016–2026
Table 20: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016–2026
Table 21: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 22: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016–2026
Table 23: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016–2026
Table 24: North America Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 25: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 26: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 27: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Product- Consumables, 2016–2026
Table 28: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016–2026
Table 29: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 30: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016–2026
Table 31: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016–2026
Table 32: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 33: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016–2026
Table 34: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016–2026
Table 35: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 36: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 37: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 38: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Consumables, 2016–2026
Table 39: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016–2026
Table 40: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 41: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016–2026
Table 42: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016–2026
Table 43: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 44: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016–2026
Table 45: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016–2026
Table 46: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 47: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 48: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 49: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Consumables, 2016–2026
Table 50: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016–2026
Table 51: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 52: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016–2026
Table 53: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016–2026
Table 54: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 55: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016–2026
Table 56: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016–2026
Table 57: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 58: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Country/Sub-regions, 2016–2026
Table 59: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 60: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Consumables, 2016–2026
Table 61: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016–2026
Table 62: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 63: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016–2026
Table 64: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016–2026
Table 65: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 66: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016–2026
Table 67: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016–2026
Table 68: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016–2026

List of Figures 

Figure 01: Multiplex Assays Market Value (US$ Mn) and Distribution by Geography, 2017 and 2026
Figure 02: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%), and Forecast, 2018–2026
Figure 03: Global Multiplex Assays Market Value Share, by Product (2018)
Figure 04: Global Multiplex Assays Market Value Share, by Technology (2018)
Figure 05: Global Multiplex Assays Market Value Share, by Type (2018)
Figure 06: Global Multiplex Assays Market Value Share, by Application (2018)
Figure 07: Global Multiplex Assays Market Value Share, by End-user (2018)
Figure 08: Global Multiplex Assays Market Value Share, by Region (2018)
Figure 09: Porter’s Five Force Analysis
Figure 10: Steps Involved in Performing Multiplex Assay
Figure 11: Value Chain Analysis
Figure 12: U.S. Regulatory Approval Process
Figure 13: Europe Regulatory Approval Process
Figure 14: Japan Regulatory Approval Process
Figure 15: India Regulatory Approval Process
Figure 16: Latin America Regulatory Approval Process 
Figure 17: Global Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
Figure 18: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Instruments, 2016–2026
Figure 19: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Consumables, 2016–2026
Figure 20: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Software, 2016–2026
Figure 21: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Reagents & Kits, 2016–2026
Figure 22: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Micropipettes and Microplates, 2016–2026
Figure 23: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
Figure 24: Global Multiplex Assays Market Attractiveness, by Product, 2018?2026
Figure 25: Global Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
Figure 26: Global Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
Figure 27: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Multiplex RT-PCR, 2016–2026
Figure 28: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Flow Cytometry, 2016–2026
Figure 29: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Luminescence, 2016–2026
Figure 30: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Fluorescence, 2016–2026
Figure 31: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
Figure 32: Global Multiplex Assays Market Attractiveness, by Technology, 2018?2026
Figure 33: Global Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
Figure 34: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Protein, 2016–2026
Figure 35: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Nucleic Acid, 2016–2026
Figure 36: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cell, 2016–2026
Figure 37: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Planar, 2016–2026
Figure 38: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Bead-based, 2016–2026
Figure 39: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Planar, 2016–2026
Figure 40: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Bead-based, 2016–2026
Figure 41: Global Multiplex Assays Market Attractiveness, by Type, 2018?2026
Figure 42: Global Multiplex Assays Market Attractiveness, by Protein, 2018?2026
Figure 43: Global Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
Figure 44: Global Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
Figure 45: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Research & Development, 2016–2026
Figure 46: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnosis, 2016–2026
Figure 47: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
Figure 48: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Drug Discovery & Development, 2016–2026
Figure 49: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biomarker research & Application, 2016–2026
Figure 50: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Infectious Diseases, 2016–2026
Figure 51: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Autoimmune Diseases, 2016–2026
Figure 52: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cancer, 2016–2026
Figure 53: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cardiovascular Diseases, 2016–2026
Figure 54: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Neuro-endocrine Diseases, 2016–2026
Figure 55: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
Figure 56: Global Multiplex Assays Market Attractiveness, by Application, 2018?2026
Figure 57: Global Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
Figure 58: Global Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
Figure 59: Global Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
Figure 60: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Academic and Research Centers, 2016–2026
Figure 61: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Centers, 2016–2026
Figure 62: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biotechnology and Biopharmaceutical Companies, 2016–2026
Figure 63: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2016–2026
Figure 64: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
Figure 65: Global Multiplex Assays Market Attractiveness, by End-user, 2018?2026
Figure 66: Global Multiplex Assays Market Value (US$ Mn) Forecast, 2016–2026
Figure 67: Global Multiplex Assays Market Value Share Analysis, by Region, 2017 and 2026
Figure 68: Global Multiplex Assays Market Attractiveness, by Region, 2018-2026
Figure 69: North America Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 70: North America Multiplex Assays Market Attractiveness Analysis, by Country, 2018–2026
Figure 71: North America Multiplex Assays Market Value Share Analysis, by Country, 2017 and 2026
Figure 72: North America Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
Figure 73: North America Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
Figure 74: North America Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
Figure 75: North America Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
Figure 76: North America Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
Figure 77: North America Multiplex Assays Market Attractiveness, by Product, 2018?2026
Figure 78: North America Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
Figure 79: North America Multiplex Assays Market Attractiveness, by Type, 2018?2026
Figure 80: North America Multiplex Assays Market Attractiveness, by Protein, 2018?2026
Figure 81: North America Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
Figure 82: North America Multiplex Assays Market Attractiveness, by Application, 2018?2026
Figure 83: North America Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
Figure 84: North America Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
Figure 85: North America Multiplex Assays Market Attractiveness, by Technology, 2018?2026
Figure 86: North America Multiplex Assays Market Attractiveness, by End-user, 2018?2026
Figure 87: Europe Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 88: Europe Multiplex Assays Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 89: Europe Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 90: Europe Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
Figure 91: Europe Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
Figure 92: Europe Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
Figure 93: Europe Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
Figure 94: Europe Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
Figure 95: Europe Multiplex Assays Market Attractiveness, by Product, 2018?2026
Figure 96: Europe Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
Figure 97: Europe Multiplex Assays Market Attractiveness, by Type, 2018?2026
Figure 98: Europe Multiplex Assays Market Attractiveness, by Protein, 2018?2026
Figure 99: Europe Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
Figure 100: Europe Multiplex Assays Market Attractiveness, by Application, 2018?2026
Figure 101: Europe Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
Figure 102: Europe Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
Figure 103: Europe Multiplex Assays Market Attractiveness, by Technology, 2018?2026
Figure 104: Europe Multiplex Assays Market Attractiveness, by End-user, 2018?2026
Figure 105: Asia Pacific Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 106: Asia Pacific Multiplex Assays Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 107: Asia Pacific Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 108: Asia Pacific Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
Figure 109: Asia Pacific Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
Figure 110: Asia Pacific Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
Figure 111: Asia Pacific Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
Figure 112: Asia Pacific Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
Figure 113: Asia Pacific Multiplex Assays Market Attractiveness, by Product, 2018?2026
Figure 114: Asia Pacific Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
Figure 115: Asia Pacific Multiplex Assays Market Attractiveness, by Type, 2018?2026
Figure 116: Asia Pacific Multiplex Assays Market Attractiveness, by Protein, 2018?2026
Figure 117: Asia Pacific Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
Figure 118: Asia Pacific Multiplex Assays Market Attractiveness, by Application, 2018?2026
Figure 119: Asia Pacific Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
Figure 120: Asia Pacific Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
Figure 121: Asia Pacific Multiplex Assays Market Attractiveness, by Technology, 2018?2026
Figure 122: Asia Pacific Multiplex Assays Market Attractiveness, by End-user, 2018?2026
Figure 123: Latin America Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 124: Latin America Multiplex Assays Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 125: Latin America Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 126: Latin America Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
Figure 127: Latin America Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
Figure 128: Latin America Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
Figure 129: Latin America Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
Figure 130: Latin America Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
Figure 131: Latin America Multiplex Assays Market Attractiveness, by Product, 2018?2026
Figure 132: Latin America Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
Figure 133: Latin America Multiplex Assays Market Attractiveness, by Type, 2018?2026
Figure 134: Latin America Multiplex Assays Market Attractiveness, by Protein, 2018?2026
Figure 135: Latin America Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
Figure 136: Latin America Multiplex Assays Market Attractiveness, by Application, 2018?2026
Figure 137: Latin America Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
Figure 138: Latin America Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
Figure 139: Latin America Multiplex Assays Market Attractiveness, by Technology, 2018?2026
Figure 140: Latin America Multiplex Assays Market Attractiveness, by End-user, 2018?2026
Figure 141: Middle East & Africa Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 142: Middle East & Africa Multiplex Assays Market Attractiveness Analysis, by Country/Sub-regions, 2018–2026
Figure 143: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 144: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
Figure 145: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
Figure 146: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
Figure 147: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
Figure 148: Middle East & Africa Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
Figure 149: Middle East & Africa Multiplex Assays Market Attractiveness, by Product, 2018?2026
Figure 150: Middle East & Africa Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
Figure 151: Middle East & Africa Multiplex Assays Market Attractiveness, by Type, 2018?2026
Figure 152: Middle East & Africa Multiplex Assays Market Attractiveness, by Protein, 2018?2026
Figure 153: Middle East & Africa Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
Figure 154: Middle East & Africa Multiplex Assays Market Attractiveness, by Application, 2018?2026
Figure 155: Middle East & Africa Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
Figure 156: Middle East & Africa Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
Figure 157: Middle East & Africa Multiplex Assays Market Attractiveness, by Technology, 2018?2026
Figure 158: Middle East & Africa Multiplex Assays Market Attractiveness, by End-user, 2018?2026

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

711

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved